Show
Sort by
-
The new Ghent criteria for Marfan syndrome: what do they change ?
-
The Ghent Marfan trial: a randomized, double-blind placebo controlled trial with losartan in Marfan patients treated with β-blockers
-
Cardiovascular manifestations in men and women carrying a FBN1 mutation
-
Clinical and molecular study of 320 children with Marfan syndrome and related type I fibrillinopathies in a series of 1009 probands with pathogenic FBN1 mutations
-
Ehlers-Danios syndromes and Marfan syndrome
-
Report of the National Heart, Lung, and Blood Institute and National Marfan Foundation working group on research in Marfan syndrome and related disorders